Cargando…

In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate

Targeted photodynamic therapy (PDT) has the potential to improve the therapeutic effect of PDT due to significantly better tumor responses and less normal tissue damage. Here we investigated if the efficacy of epidermal growth factor receptor (EGFR) targeted PDT using cetuximab-IRDye700DX is fluence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Wei, de Bruijn, Henriette S., ten Hagen, Timo L. M., Berg, Kristian, Roodenburg, Jan L. N., van Dam, Go M., Witjes, Max J. H., Robinson, Dominic J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017190/ https://www.ncbi.nlm.nih.gov/pubmed/31940973 http://dx.doi.org/10.3390/cancers12010190

Ejemplares similares

Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti‐epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin‐fold Window Chamber Model
por: Peng, Wei, et al.
Publicado: (2020)

Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin
por: de Bruijn, Henriëtte S., et al.
Publicado: (2016)

In vivo monitoring of Foscan-mediated photodynamic therapy in clinical head and neck procedures using optical spectroscopy
por: Kanick, Stephen, et al.
Publicado: (2010)

Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy
por: Ngo, Wei Kiong, et al.
Publicado: (2020)

Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
por: Kaščáková, Slávka, et al.
Publicado: (2014)

Acute cellular and vascular responses to photodynamic therapy using EGFR-targeted nanobody-photosensitizer conjugates studied with intravital optical imaging and magnetic resonance imaging
por: de Bruijn, Henriette S., et al.
Publicado: (2020)

Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions
por: van Straten, Demian, et al.
Publicado: (2017)

Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity
por: Grossman, Craig E., et al.
Publicado: (2016)

Long-Term Effect of Half-Fluence Photodynamic Therapy on Fundus Autofluorescence in Acute Central Serous Chorioretinopathy
por: Stattin, Martin, et al.
Publicado: (2020)

Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
por: Sitnik, T. M., et al.
Publicado: (1998)

Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy
por: Chubachi-Kamimura, Aya, et al.
Publicado: (2023)

Non-invasive measurement of photosensitiser concentration using fluorescence differential path-length spectroscopy: validation for different liposomal formulations of m-THPC: Foscan, Foslip and Fospeg
por: de Visscher, Sebastiaan, et al.
Publicado: (2010)

Half-Fluence, Half-Dose Photodynamic Therapy: Less Direct Damage but More Inflammation?
por: Desmettre, Thomas, et al.
Publicado: (2023)

Low-fluence photodynamic therapy for early onset choroidal neovascular membrane following laser in situ keratomileusis
por: Manayath, George J, et al.
Publicado: (2012)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011)

Half-fluence photodynamic therapy to treat chronic central serous chorioretinopathy: A case series
por: Al-Hinai, Ahmed S., et al.
Publicado: (2011)

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

Efficacy of reduced-fluence photodynamic therapy for serous retinal pigment epithelial detachment with choroidal hyperpermeability
por: Shibata, Asako, et al.
Publicado: (2013)

Choroidal vascularity changes in idiopathic central serous chorioretinopathy after half-fluence photodynamic therapy
por: Ma, Dae Joong, et al.
Publicado: (2018)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
por: Sakurai, Madoka, et al.
Publicado: (2014)

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2022)

Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis
por: Aisu, Nao, et al.
Publicado: (2022)

Computational Optimization of Irradiance and Fluence for Interstitial Photodynamic Therapy Treatment of Patients with Malignant Central Airway Obstruction
por: Oakley, Emily, et al.
Publicado: (2023)

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy
por: Alkin, Zeynep, et al.
Publicado: (2014)

Reduced-fluence photodynamic therapy and anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy in an Indian population
por: Sen, Parveen, et al.
Publicado: (2016)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
por: Kim, Min Ho, et al.
Publicado: (2021)

Normalization of optical fluence distribution for three-dimensional functional optoacoustic tomography of the breast
por: Park, Seonyeong, et al.
Publicado: (2022)

Photodynamic therapy monitoring with optical coherence angiography
por: Sirotkina, M. A., et al.
Publicado: (2017)

Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
por: Özmert, Emin, et al.
Publicado: (2016)

Progressive high-fluence epithelium-on accelerated corneal crosslinking: a novel corneal photodynamic therapy for early progressive keratoconus
por: Mazzotta, Cosimo, et al.
Publicado: (2023)

Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC
por: Murrer, L H P, et al.
Publicado: (1999)

Optical Properties and Fluence Distribution in Rabbit Head Tissues at Selected Laser Wavelengths
por: Shanshool, Alaa Sabeeh, et al.
Publicado: (2022)

Silicon Sensors for Extreme Fluences
por: Sola, V., et al.
Publicado: (2020)

Fluence determination by scattering measurements
por: Albergo, S, et al.
Publicado: (2000)

25-Gauge Vitrectomy Combined with Half-Fluence Photodynamic Therapy for the Treatment of Juxtapapillary Retinal Capillary Hemangioma: A Case Report
por: Mariotti, Cesare, et al.
Publicado: (2014)

Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020)

Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
por: Yamada, Chizu, et al.
Publicado: (2022)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
por: Williams, Patrick D, et al.
Publicado: (2012)

A Method for Medical Diagnosis Based on Optical Fluence Rate Distribution at Tissue Surface
por: Hamdy, Omnia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ufa7jhfo6rqlosa6a0mirgsed